1Research progress on pathological mechanism of paroxysmal nocturnal hemoglobinuriaFU Rong, LI Li-yanSYMPOSIUM529-5342Progress in treatment of paroxysmal nocturnal hemoglobinuriaHAN BingSYMPOSIUM535-5393Diagnosis and treatment of immuno-related hemocytopenia/pancytopeniaWANG Yi-hao, FU Rong, SHAO Zong-hongSYMPOSIUM540-5454Treatment options for low-risk myelodysplastic syndromeLI Li-juan, MA Tao, ZHANG Lian-shengSYMPOSIUM546-5515Pathological mechanism and targeted drug therapy of myelodysplastic syndromeYANG Fei, SHI JunSYMPOSIUM552-5566Prognosis of severe aplastic anemia patients with platelet transfusion refractory following immunosuppressive therapyWANG Shi-chong, GE Mei-li, LI Xing-xin, SHAO Ying-qi, HUANG Jin-bo, HUO Jia-li, REN Xiang, ZHANG Jing, WANG Min, NIE Neng, JIN Peng, ZHENG Yi-zhouORIGINAL CONTRIBUTION557-562,5677Distribution of 21 hydroxylase antibody in different types of diabetes mellitusREN Ya-ping, HUANG Gan, YANG Yi-fenORIGINAL CONTRIBUTION563-5678A family report of congenital polycythemia caused by EPOR truncation mutation and literature reviewHAN Ying-di, ZHANG Yu-hui, GAO Chao, HU Nai-bo, TENG Guang-shuai, WANG Yan, DU Chen-xiao, CHEN Ya-fang, LI Yan-qi, ZAHNG Hui-qin, PENG Lan, LIU YI, BAI JieORIGINAL CONTRIBUTION568-5729Efficacy and safety of eltrombopag combined with cyclosporine A in the treatment of severe aplastic anemiaJIAO Wen-jing, LIU Li-min, ZHOU Hui-fen, WANG Qing-yuan, MIAO miao, WU De-peiORIGINAL CONTRIBUTION573-57610Application of Argatroban in bedside hemofiltration in patients with high risk of bleedingWANG Xin-bo, DU Yin-ke, GENG Ye, YAO LiORIGINAL CONTRIBUTION577-58111The Disease Burden and Intervention Strategy for Chronic HyperkalemiaJIANG Geng-ruCOLOMN OF HYPERKALEMIA612-616